Hel Ved Capital Management Ltd Has $2.77 Million Position in Lam Research Corporation $LRCX

Hel Ved Capital Management Ltd reduced its holdings in Lam Research Corporation (NASDAQ:LRCX) by 78.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,450 shares of the semiconductor company’s stock after selling 105,250 shares during the period. Hel Ved Capital Management Ltd’s holdings in Lam Research were worth $2,769,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of LRCX. Brighton Jones LLC grew its position in Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after purchasing an additional 12,936 shares in the last quarter. Mutual of America Capital Management LLC acquired a new stake in shares of Lam Research during the 1st quarter valued at $13,345,000. Avantax Advisory Services Inc. grew its holdings in shares of Lam Research by 20.1% during the 1st quarter. Avantax Advisory Services Inc. now owns 47,336 shares of the semiconductor company’s stock valued at $3,441,000 after acquiring an additional 7,929 shares in the last quarter. LPL Financial LLC increased its stake in shares of Lam Research by 4.6% in the first quarter. LPL Financial LLC now owns 1,155,707 shares of the semiconductor company’s stock worth $84,020,000 after acquiring an additional 51,280 shares during the last quarter. Finally, Meeder Advisory Services Inc. raised its holdings in shares of Lam Research by 12.3% during the first quarter. Meeder Advisory Services Inc. now owns 35,180 shares of the semiconductor company’s stock worth $2,558,000 after acquiring an additional 3,849 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Lam Research

In related news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the transaction, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 102,608 shares of company stock worth $14,916,496. Insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

LRCX has been the topic of a number of recent research reports. Susquehanna boosted their target price on Lam Research from $135.00 to $200.00 and gave the company a “positive” rating in a research note on Thursday, October 23rd. Cowen restated a “buy” rating on shares of Lam Research in a report on Thursday, October 23rd. Sanford C. Bernstein lifted their target price on shares of Lam Research from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Friday, November 21st. Barclays set a $142.00 target price on shares of Lam Research and gave the stock an “equal weight” rating in a research report on Monday, October 20th. Finally, Needham & Company LLC raised their price target on shares of Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Twenty-six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $152.17.

Lam Research Stock Up 1.0%

LRCX stock opened at $151.93 on Wednesday. The stock has a market capitalization of $190.83 billion, a price-to-earnings ratio of 33.46, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The company has a 50-day moving average of $145.43 and a two-hundred day moving average of $113.50. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the previous year, the firm earned $0.86 EPS. The firm’s revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, equities research analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.